SPIEGELMAN DANIEL K bought MAZE
September 22, 2025 · Form 4 insider transaction
SPIEGELMAN DANIEL K bought 18,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,000
Price
$0.00
Total value
N/A
InsiderSPIEGELMAN DANIEL K
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 22, 2025
Filing dateSeptember 24, 2025
Shares owned after18,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date.